Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804.
PMID:23587576
Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts.
Baratti MO, Moreira YB, Traina F, Costa FF, Verjovski-Almeida S, Olalla-Saad ST.
BMC Med Genomics. 2010 Jul 15;3:30. doi: 10.1186/1755-8794-3-30.
PMID:20633296
Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
Leukemia. 1996 Jan;10(1):20-6.
PMID:8558932
Myelodysplastic syndromes: prognostic significance of multilineage dysplasia in patients with refractory anemia or refractory anemia with ringed sideroblasts.
Dunkley SM, Manoharan A, Kwan YL.
Blood. 2002 May 15;99(10):3870-1; author reply 3871. doi: 10.1182/blood-2001-11-0120.
PMID:12014369
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.
Haematologica. 2006 Dec;91(12):1596-604.
PMID:17145595
DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome.
Ribeiro HL Jr, Maia ARS, de Oliveira RTG, Costa MB, Farias IR, de Paula Borges D, de Sousa JC, Magalhães SMM, Pinheiro RF.